Impact of interseed attenuation and tissue composition for permanent prostate implants

Medical Physics

Volumn 33, Issue 3, 2006, Pages 595-604

  Carrier, Jean François ^b   Beaulieu, Luc ^c   Therriault Proulx, François ^a   Roy, René ^a  

^a UNIVERSITÉ LAVAL   (Canada)

^b NOTRE DAME HOSPITAL   (Canada)

^c NONE

Author keywords

Dosimetry; GEANT4; Monte Carlo; Prostate brachytherapy

Indexed keywords

DOSIMETRY; DROPS; MONTE CARLO METHODS; RESPIRATORY MECHANICS; TISSUE;

CLINICAL EFFECTS; DOSE CALCULATION; GEANT4; INTERNATIONAL COMMISSION ON RADIOLOGICAL PROTECTIONS; PROSTATE BRACHYTHERAPY; PROSTATE IMPLANTS; PROSTATE TREATMENT; TISSUE COMPOSITION;

UROLOGY;

CALCIUM; CARBON; HYDROGEN; IODINE 125; MAGNESIUM; NITROGEN; WATER;

ACCURACY; ANISOTROPY; ARTICLE; DENSITY; DOSIMETRY; HISTOGRAM; IMPLANT; MONTE CARLO METHOD; ORGAN SIZE; PRIORITY JOURNAL; PROSTATE; RADIATION DOSE DISTRIBUTION; RADIATION SCATTERING; TREATMENT PLANNING; VALIDATION PROCESS;

EID: 33644624376     PISSN: 00942405     EISSN: None     Source Type: Journal    
DOI: 10.1118/1.2168295     Document Type: Article

References (46)

1. H. H. Holm and J. Gammelgaard, " Ultrasonically guided precise needle placement in the prostate and the seminal vesicles., " J. Urol. (Baltimore) 125, 385-387 (1981).
2. H. H. Holm, J. F. Pederson, H. Hansen, and I. Stroyer, " Transperineal I-125 iodine seed implantation in prostatic cancer guided by transrectal ultrasonography., " J. Urol. (Baltimore) 130, 283-286 (1983).
3. H. Ragde, A. A. Elgamal, P. B. Snow, J. Brandt, A. A. Bartolucci, B. S. Nadir, and L. J. Korb, " Ten-year disease free survival after transperineal sonography-guided iodine-125 brachytherapy with or without 45-gray external beam irradiation in the treatment of patients with clinically localized, low to high Gleason grade prostate carcinoma., " Cancer 83, 989-1001 (1998).
4. D. C. Beyer and J. B. Priestley, Jr., " Biochemical disease-free survival following 125I prostate implantation., " Int. J. Radiat. Oncol., Biol., Phys. 37, 559-563 (1997).
5. J. Wallner, J. Roy, and L. Harrison, " Tumor control and morbidity following transperineal iodine 125 implantation for stage T1/T2 prostatic carcinoma., " J. Clin. Oncol. 14, 449-453 (1996).
6. M. Storey, " Transperineal 125-iodine implantation for treatment of clinically localized prostate cancer: 5-year tumor control and morbidity., " Int. J. Radiat. Oncol., Biol., Phys. 43, 565-570 (1999).
7. H. Ragde, L. J. Korb, A. A. Elgamal, G. L. Grado, and B. S. Nadir, " Modern prostate brachytherapy. Prostate specific antigen results in 219 patients with up to 12 years of observed follow-up., " Cancer 89, 135-141 (2000).
8. P. D. Grimm, J. C. Blasko, J. E. Sylvester, R. M. Meier, and W. Cavanagh, " 10-year biochemical (prostate-specific antigen) control of prostate cancer with (125)I brachytherapy., " Int. J. Radiat. Oncol., Biol., Phys. 51, 31-40 (2001).
9. G. S. Merrick, W. M. Butler, R. W. Galbreath, and J. H. Lief, " Five-year biochemical outcome following permanent interstitial brachytherapy for clinical T1-T3 prostate cancer., " Int. J. Radiat. Oncol., Biol., Phys. 51, 41-48 (2001).
10. A. V. D'Amico, " Biochemical outcome after radical prostatectomy, external beam radiation therapy, or interstitial radiation therapy for clinically localized prostate cancer., " J. Am. Med. Assoc. 280, 969-974 (1998).
11. M. J. Zelefsky, " Comparison of the 5-year outcome and morbidity of three-dimensional conformal radiotherapy versus transperineal permanent iodine-125 implantation for early-stage prostatic cancer., " J. Clin. Oncol. 17, 517-522 (1999).
12. M. J. Zelefsky, S. A. Leibel, P. B. Gaudin, G. J. Kutcher, N. E. Fleshner, E. S. Venkatramen, V. E. Reuter, W. R. Fair, C. C. Ling, and Z. Fuks, " Dose escalation with three-dimensional conformal radiation therapy affects the outcome prostate cancer., " Int. J. Radiat. Oncol., Biol., Phys. 41, 491-500 (1998).
13. A. Pollack, G. K. Zagars, L. G. Smith, J. J. Lee, A. C. von Eschenbach, J. A. Antolak, G. Starkschall, and I. Rosen, " Preliminary results of a randomized radiotherapy dose-escalation study comparing 70 Gy with 78 Gy for prostate cancer., " J. Clin. Oncol. 18, 3904-3911 (2000).
14. R. G. Stock, N. N. Stone, A. Tabert, C. Iannuzzi, and J. K. DeWyngaert, " A dose-response study for I-125 prostate implants., " Int. J. Radiat. Oncol., Biol., Phys. 41, 101-108 (1998).
15. R. Nath, L. L. Anderson, G. Luxton, K. A. Weaver, J. F. Williamson, and A. S. Meigooni, " Dosimetry of interstitial brachytherapy sources: Recommendations of the AAPM Radiation Therapy Committee Task Group No. 43., " Med. Phys. 22, 209-230 (1995).
16. Y. Yu, " Permanent prostate seed implant brachytherapy: Report of the American Association of Physicists in Medecine Task Group No. 64., " Med. Phys. 26, 2054-2076 (1999).
17. P. Mobit and I. Badragan, " Dose perturbation effects in prostate seed implant brachytherapy with I-125., " Phys. Med. Biol. 49, 3171-3178 (2004).
18. O. Chibani, J. F. Williamson, and D. Todor, " Dosimetric effects of seed anisotropy and interseed attenuation for 103Pd and 125I prostate implants., " Med. Phys. 32, 2557-2566 (2005).
19. L. Beaulieu, L. Archambault, S. Aubin, E. Oral, R. Taschereau, and J. Pouliot, " The robustness of dose distributions to displacement and migration of 125I permanent seed implants over a wide range of seed number, activity, and designs., " Int. J. Radiat. Oncol., Biol., Phys. 58, 1298-1308 (2004).
20. J. Pouliot, D. Tremblay, J. Roy, and S. Filice, " Optimization of permanent 125I prostate implants using fast simulated annealing., " Int. J. Radiat. Oncol., Biol., Phys. 36, 711-720 (1996).
21. G. Leclerc, M. C. Lavallee, D. Tubic, J. Metivier, E. Vigneault, and L. Beaulieu, " Idealized line source configuration for permanent I-125 prostate implants., " Radiother. Oncol. 72, 213-220 (2004).
22. M. J. Rivard, B. M. Coursey, L. A. DeWerd, W. F. Hanson, M. S. Huq, G. S. Ibbott, M. G. Mitch, R. Nath, and J. F. Williamson, " Update of the AAPM Task Group No. 43 Report: A revised AAPM protocol for brachytherapy dose calculations., " Med. Phys. 31, 633-674 (2004).
23. W. S. Snyder, M. J. Cook, E. S. Nasset, L. R. Karkhausen, G. P. Howells, and I. H. Tipton, " Report of the task group on reference man., " Technical Report 23, International Commission on Radiological Protection, 1974.
24. V. O. Zilio, O. P. Joneja, Y. Popowski, and R. Chawla, " Dosimetric characterization of radioactive sources employed in prostate cancer therapy., " Brachytherapy 3, 201-214 (2004).
25. S. Agostinelli, " GEANT4-A simulation toolkit., " Nucl. Instrum. Methods Phys. Res. A 506, 250-303 (2003).
26. J. -F. Carrier, L. Archambault, R. Roy, and L. Beaulieu, " Validation of GEANT4, an object-oriented Monte Carlo toolkit, for simulations in medical physics., " Med. Phys. 31, 484-492 (2004).
27. R. Taschereau, R. Roy, and J. Pouliot, " Relative biological effectiveness enhancement of a I-125 brachytherapy seed with characteristic x rays from its constitutive materials., " Med. Phys. 29, 1397-1402 (2002).
28. D. Perez-Calatayud, D. Granero, E. Casal, and F. Ballester, " Monte Carlo and experimental derivation of TG43 dosimetric parameters for CSM-type Cs-137 sources., " Med. Phys. 32, 28-36 (2004).
29. F. Ballester, D. Granero, D. Perez-Calatayud, E. Casal, and V. Puchades, " Monte Carlo dosimetric study of Best Industries and Alpha Omega Ir-192 brachytherapy seeds., " Med. Phys. 31, 3298-3305 (2004).
30. D. Cullen, The Evaluated Photon Data Library, 97 version, 1997, UCRL-50400, Vol. 6, Rev 5.
31. S. T. Perkins, Table and graphs of electron interaction cross sections from 10 eV to 100 GeV derived from the LLNL Evaluated Electron Data Library (EEDL), 1997, UCRL-50400, Vol. 31.
32. S. T. Perkins, Table and graphs of atomic subshells and relaxation data derived from the LLNL Evaluated Atomic Data Library (EADL), Z=1-100, 1997, UCRL-50400, Vol. 30.
33. E. Poon, J. Seuntjens, and F. Verhaegen, " Consistency test of the electron transport algorithm in the GEANT4 Monte Carlo code., " Phys. Med. Biol. 50, 681-694 (2005).
34. J. F. Williamson, B. M. Coursey, L. A. DeWerd, W. F. Hanson, R. Nath, and G. S. Ibbott, " Guidance to users of Nycomed Amersham and North American Scientific, Inc., I-125 Interstitial Sources: Dosimetry and calibration changes: Recommendations of the American Association of Physicists in Medicine Radiation Therapy Committee Ad Hoc Subcommittee on Low-Energy Seed Dosimetry., " Med. Phys. 26, 570-573 (1999).
35. C. C. Ling, E. D. York, I. J. Spiro, D. Kubiatowicz, and D. Bennett, " Physical dosimetry of I-125 seeds of a new design for interstitial implant., " Int. J. Radiat. Oncol., Biol., Phys. 9, 1747-1752 (1983).
36. H. Kubo, " Exposure contribution from Ti K x-rays produced in the titanium capsule of the clinical I-125 seed., " Med. Phys. 12, 215-220 (1985).
37. T. D. Bohm, P. M. DeLuca, and L. A. DeWerd, " Brachytherapy dosimetry of I125 and Pd103 sources using an updated cross section library for the MCNP Monte Carlo transport code., " Med. Phys. 30, 701-711 (2003).
38. B. Reniers, F. Verhaegen, and S. Vynckier, " The radial dose function of low energy brachytherapy seeds in different solid phantoms: Comparison between calculations with the EGSnrc and MCNP4C Monte Carlo codes and measurements., " Phys. Med. Biol. 49, 1569-1582 (2004).
39. B. H. Heintz, R. E. Wallace, and J. M. Hevezi, " Comparison of I-125 sources used for permanent interstitial implants., " Phys. Med. Biol. 28, 671-682 (2001).
40. E. Mainegra, R. Capote, and E. Lopez, " Radial dose function for Pd103, I125, Yb169 and Ir192 brachytherapy sources: An EGS4 Monte Carlo study., " Phys. Med. Biol. 45, 703-717 (2000).
41. J. F. Williamson, " Comparison of measured and calculated dose rates in water near I-125 and Ir-192 seeds., " Phys. Med. Biol. 18, 776-786 (1991).
42. K. Weaver, " Anisotropy functions for I125 and Pd103 sources., " Phys. Med. Biol. 25, 2271-2278 (1998).
43. R. Capote, E. Mainegra, and E. Lopez, " Anisotropy functions for low energy interstitial brachytherapy sources: An EGS4 Monte Carlo study., " Phys. Med. Biol. 46, 135-150 (2001).
44. J. F. Williamson, " Monte Carlo modeling of the transverse-axis dose distribution of the Model 200 103Pd interstitial brachytherapy source., " Med. Phys. 27, 2528-2535 (2000).
45. D. Tubic and L. Beaulieu, " Sliding slice: A novel approach for high accuracy and automatic 3D localization of seeds from CT scans., " Med. Phys. 32, 163-74 (2005).
46. M. Yazdi and L. Beaulieu, " An adaptive approach of metal artifact reduction in helical CT for radiation therapy treatment planning: Experimental and clinical studies., " Int. J. Radiat. Oncol., Biol., Phys. 62, 1224-1231 (2005).